Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

168 HR Clonidine 0.00833 MG/HR Transdermal System

Known as: CLONIDINE 0.2 mg in 1 d TRANSDERMAL PATCH [Clonidine], cloNIDine HCl 0.2 MG/Day Weekly Transdermal System, Clonidine 0.2 mg in 1 d TRANSDERMAL PATCH 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The current investigation sought to determine whether a standard outpatient dose of dialectical behavior therapy (DBT) skills… Expand
  • table 1
Is this relevant?
2007
2007
A33 Background: VEGFR-2 is a key regulator of angiogenesis and cancer cell growth. IMC-1121B is a recombinant human IgG1 MAb… Expand
Is this relevant?
2006
2006
Background: We wished to define the maximum tolerated dose (MTD), toxicity, and pharmacokinetics of the novel isoflav-3-ene, NV06… Expand
  • table 3
  • table 1
  • table 4
  • table 2
  • table 5
Is this relevant?
2005
2005
In view of the recent interest in weekly erythropoietic regimens and the lack of studies directly comparing the available agents… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
3031 Background: 17AAG is a benzoquinone antibiotic known to down regulate oncoproteins, by binding to heat shock protein 90… Expand
Is this relevant?
2004
2004
3031 Background: 17AAG is a benzoquinone antibiotic known to down regulate oncoproteins, by binding to heat shock protein 90… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
In this study, the processes affecting sea surface temperature variability over the 1992-98 period, encompassing the very strong… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 4
Is this relevant?